1030828-84-2

Upstream product

• 540-38-5 p-Iodophenol 
• 623-47-2 propynoic acid ethyl ester 

Downstream Products

• 1030829-56-1 ethyl 3-[4-(benzyloxy)phenyl]prop-2-ynoate 
• 1030829-03-8 C₂₂H₂₃NO₄ 
• 1030829-06-1 ethyl 3-(4-((2-isopropoxypyridin-3-yl)methoxy)phenyl)prop-2-ynoate 
• 73583-44-5 3-(4-(benzyloxy)phenyl)propiolic acid 
• 78589-65-8 3-(4-hydroxyphenyl)prop-2-yn-1-oic acid 
• 1312786-88-1 5-(4-((3-phenoxyphenyl)methoxy)phenyl)isothiazol-3-ol 
• 1312786-89-2 5-(4-((3-phenoxyphenyl)methoxy)phenyl)isothiazol-3-ol 1-oxide 
• 1312786-90-5 5-(4-(benzyloxy)phenyl)isothiazol-3-ol 
• 1312786-91-6 5-(4-(benzyloxy)phenyl)isothiazol-3-ol 1-oxide 
• 1312788-37-6 3-(4-hydroxyphenyl)propiolic acid amide 
• 1312788-38-7 3-(4-((3-phenoxyphenyl)methoxy)phenyl)propiolic acid amide 
• 1312788-39-8 3-(4-(benzyloxy)phenyl)propiolic acid amide 
• 1312788-40-1 5-(4-(benzyloxy)phenyl)-3-(tert-butyldimethylsiloxy)isothiazole 
• 1294453-89-6 > 3-[4-[[3-[4-(3-hydroxy-3-methylbutoxy)-2,6-dimethylphenyl]-2-methylphenyl]methoxy]phenyl]prop-2-ynoic acid ethyl ester 

Relevant academic research and scientific papers

Composition for forming anisotropic dye film, anisotropic dye film, and optical element (by machine translation)

The present invention provides a composition for forming an anisotropic dye film, which is capable of achieving excellent optical performance, and in particular, capable of achieving sufficient dichroic ratio. The composition for forming an anisotropic dye film of the present invention contains a dye and a polymerizable liquid crystal compound, and the dye contains a compound represented by the formula (1). A1 - CH=CH - A2 - (N=N - A3) n-X(1) (wherein A1 represents 1-valent or may have a substituent (except for a sulfo group) 1-valent group of an aromatic hydrocarbon ring having a substituent (excluding sulfo group); A2 and A3 each independently represent a substituent (except for a sulfo group) and an aromatic heterocyclic ring having a substituent (except for a sulfo group)).) 2-valyl group or 2-valyl group having a substituent (except for a sulfo group). (wherein n represents 1 2, 3 1). (by machine translation)

NOVEL 3-HYDROXY-5-ARYLISOTHIAZOLE DERIVATIVE

[Problem] To provide a GPR40 activating agent having, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the salt or the compound, or the like, particularly, an insulin secretagogue and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases. [Means of solving the problem] A compound of Formula (I): (where n is 0 to 2; p is 0 to 4; j is 0 to 3; k is 0 to 2; a ring A is an aryl group which is optionally substituted with L or a heterocyclic group which is optionally substituted with L; a ring B is a benzene ring, a pyridine ring, or a pyrimidine ring; X is O, S, —NR7—; and R1 to R7 are specific groups), a salt of the compound, or a solvate of the salt or the compound.

NOVEL ISOXAZOLE DRIVATIVE

Disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an agonistic activity on GPR120 and is therefore useful for the treatment of diabetes, obesity or hyperlipemia. [In formula (I), the A represents a phenyl group which may be substituted by a lower alkoxy group or the like; the 13 represents a bivalent group produced by removing two hydrogen atoms from a benzene ring which may be substituted by a halogen atom or the like; X represents a lower alkylene group having 2 to 4 carbon atoms in its main chain or the like, wherein a carbon atom constituting the main chain may be substituted by an oxygen atom or the like; and Y represents a hydrogen atom or the like.]

NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE

The present invention relates to a compound represented by formula (I), which has a GPR120 agonist action and thus is useful for treatment of diabetes mellitus or hyperlipidemia, or a pharmaceutically acceptable salt thereof. In the formula, (AA) represents a phenyl or the like, which may be substituted with a lower alkoxy group or the like; (BB) represents a divalent group or the like, derived by removal of two hydrogen atoms from a benzene which may be substituted with a halogen atom or the like; X represents a spacer having a main chain composed of 1-8 carbon atoms wherein 1-3 carbon atoms in the main chain may be substituted with an oxygen atom or the like; and Y represents a hydrogen atom or the like.